 "Industry says $6 to $18 per dose is reasonable price for Covid-19 vaccine")
BRUSSELS (Reuters) - A senior pharmaceutical industry official said on Tuesday that a price range between 5 and 15 euros ($6 to $18) per dose was reasonable for COVID-19 vaccines.
A price between 5 and 15 euros a dose "is a reasonable price for a vaccine," Sue Middleton, President of the Executive Board, of Vaccines Europe told a hearing in the EU Parliament.
Vaccines Europe represents big pharmaceutical companies.
($1 = 0.8522 euros)
(Reporting by Francesco Guarascio, editing by Louise Heavens)
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app